openPR Logo
Press release

Tech Stocks LABT, ANY, INLF, GMGMF, ZCMD Under $2 Watch Now

07-23-2026 07:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Tech Stocks LABT, ANY, INLF, GMGMF, ZCMD Under $2 Watch Now

As investors continue searching for emerging growth opportunities, several technology, biotechnology, healthcare, industrial automation, and digital infrastructure companies trading under $2 are attracting attention following recent corporate developments spanning Artificial Intelligence (AI), AI Infrastructure, Robotics, Healthcare Technology, Graphene, and Advanced Manufacturing.

Lakewood-Amedex Biotherapeutics, Inc. (NASDAQ: LABT) continues advancing its proprietary antimicrobial platform as global concern surrounding antimicrobial resistance (AMR) intensifies. The Company recently reported new laboratory data supporting its Phase 2-ready lead candidate, Nu-3, for the treatment of infected diabetic foot ulcers. Unlike many conventional antibiotics, Nu-3 utilizes Lakewood-Amedex's proprietary Bisphosphocin Registered technology to physically disrupt bacterial membranes, demonstrating a high barrier to resistance during laboratory testing. The announcement follows renewed national attention after the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) discussed priorities for the next U.S. National Action Plan addressing drug-resistant infections.

Sphere 3D Corp. (NASDAQ: ANY) continues executing its transformation into a diversified AI Infrastructure, Digital Infrastructure, Data Center, and Power-Backed Computing company. Recent initiatives include expanding government affairs efforts across the Tennessee Valley Authority (TVA) region while evaluating approximately 53 MW of power-ready infrastructure for Artificial Intelligence, High-Performance Computing (HPC), GPU Infrastructure, and Cloud Computing deployments. The Company also recently announced a 30 MWpartnership with Bitdeer Technologies Group (NASDAQ: BTDR) and proposed a corporate rebranding to DarkHorse Technologies Inc. Following a pullback from its June 2026 high of $5.65, investors continue monitoring the stock as interest builds around companies positioned to benefit from expanding AI infrastructure demand.

INLIF Ltd. (NASDAQ: INLF) has attracted attention following strong early trading activity. The Company designs and manufactures a broad portfolio of industrial automation equipment, including advanced injection molding robotic manipulator systems, multi-axis automation solutions, intelligent robotics, and automation technologies supporting manufacturing and energy-sector applications. Growing investment in industrial automation and intelligent manufacturing continues to drive interest in companies serving these expanding markets.

Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) recently announced a global exclusive Memorandum of Understanding with Alstomto jointly develop and commercialize graphene-enhanced HVAC solutions for the global rail industry. The agreement expands GMG's presence in transportation infrastructure while further validating its proprietary graphene technology. The announcement follows record sales orders, completion of the Company's Generation 2.0 Graphene Manufacturing Plant, and growing adoption of graphene technologies across HVAC, industrial cooling, AI Data Centers, and commercial infrastructure applications.

Zhongchao Inc. (NASDAQ: ZCMD) also gained investor attention following increased trading activity. The healthcare technology company provides digital patient management services focused on oncology and rare diseases while operating its online medical information platform, Sunshine Health Forums. As healthcare continues embracing digital transformation, investors remain focused on companies expanding Healthcare Technology, Telemedicine, and online medical services.

As interest continues building around Artificial Intelligence, Healthcare Technology, Industrial Automation, Digital Infrastructure, Graphene, and next-generation technology companies, LABT, ANY, INLF, GMGMF, and ZCMD remain among the lower-priced growth stocks investors are watching for potential catalysts.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=tech-stocks-labt-any-inlf-gmgmf-zcmd-under-2-watch-now]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tech Stocks LABT, ANY, INLF, GMGMF, ZCMD Under $2 Watch Now here

News-ID: 4585244 • Views:

More Releases from ABNewswire

Precision Biotics Market Projected to Reach $9.26 billion by 2031 | Top Companies are BioGaia (Sweden) and Novonesis Group (Denmark)
Precision Biotics Market Projected to Reach $9.26 billion by 2031 | Top Companie …
Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End-use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031 The precision biotics market [https://www.marketsandmarkets.com/Market-Reports/precision-biotics-market-110337959.html] is projected to grow from USD 4.91 billion in 2026 to reach USD 9.26 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.5% during the forecast period. The global precision biotics market is experiencing steady growth. This can be
NLP in Healthcare & Life Sciences Market to Surge to USD 30.06 Billion by 2031, AI-Driven Clinical Documentation and Precision Medicine Fuel Demand | Report by MarketsandMarkets Trademark
NLP in Healthcare & Life Sciences Market to Surge to USD 30.06 Billion by 2031, …
NLP in Healthcare & Life Sciences Market by Offering (Software, Services), Technology (Rule-based & Symbolic NLP, Statistical & Classical Machine Learning NLP), End User (Healthcare Providers, Healthcare Payers) - Global Forecast to 2031. According to MarketsandMarkets Trademark , the NLP in Healthcare & Life Sciences market [https://www.marketsandmarkets.com/Market-Reports/healthcare-lifesciences-nlp-market-131821021.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=healthcarelifesciencesnlpmarket] size was valued at USD 5.92 billion in 2025 and is projected to grow from USD 8.14 billion in 2026 to USD 30.06 billion
Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) Signs Exclusive Global Rail Agreement with Alstom
Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) Signs Exclusive Global Rail Ag …
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) has announced a global exclusive Memorandum of Understanding (MOU)with Alstom (EPA: ALO) to jointly develop and commercialize graphene-enhanced HVAC products for the global rail industry. The agreement represents major commercial validation for GMG, providing the company with an exclusive opportunity to work alongside one of the world's largest rail manufacturers. Alstom operates in 61 countries, employs approximately 87,800 people, and generated 19.2 billion
Vertos Market Launches New Marketplace to Help Founders Turn Digital Projects Into Valuable Business Assets
Vertos Market Launches New Marketplace to Help Founders Turn Digital Projects In …
The new platform connects buyers and sellers of AI-built businesses, SaaS products, websites, and digital assets, creating new opportunities for entrepreneurs and investors. Image: https://www.abnewswire.com/upload/2026/07/c99232418e609205f2ae32e502ce78f4.jpg July 23, 2026 - The rapid rise of artificial intelligence has transformed the way software is created. Tasks that once required months of development can now be completed in weeks or even days, enabling entrepreneurs to launch websites, SaaS platforms, mobile apps, AI tools, Chrome extensions, and

All 5 Releases


More Releases for GMG

Which Companies Lead the Generalized Myasthenia Gravis Treatment (gMG) Market in …
DataM Intelligence has published its latest research report, "Generalized Myasthenia Gravis Treatment Market Size 2026." The report provides comprehensive analysis of market dynamics, including regional growth patterns, segment-wise performance, CAGR forecasts, competitive positioning, and revenue trends across key industry participants. It also examines the major factors influencing market expansion, emerging business opportunities, and strategic developments. Designed to support informed business planning, the study delivers a clear assessment of market value,
Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) CEO Discusses Commercial Graph …
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) continues to build momentum as the company expands production, secures new commercial partnerships, and advances the commercialization of its graphene technology platform. Founder and CEO Craig Nicol recently appeared on CEO.CA to discuss GMG's growing ability to manufacture and sell its expanding portfolio of graphene-based products. Watch the interview Now! [https://youtu.be/BV39Ikllstc] GMG has evolved beyond the research stage and is increasingly focused on
Dual-Listed Stocks GMG, AMLM, PNPN, BB in the U.S. and Canada to Watch
As investors continue searching for opportunities tied to critical minerals, energy efficiency, electrification, cybersecurity, artificial intelligence, and advanced manufacturing, several companies trading in both the United States and Canada are drawing increased attention. Among them are Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF), American Lithium Minerals (OTC: AMLM), Power Metallic Mines Inc. (TSXV: PNPN) (OTCQB: PNPNF), and BlackBerry Limited (NYSE: BB) (TSX: BB). Graphene Manufacturing Group (GMG) continues expanding its
Generalized Myasthenia Gravis (gMG) Market Enters Strong Growth Nearly USD 3.2 b …
Generalized Myasthenia Gravis (gMG) Market Enters Strong Growth Phase with Breakthrough Biologic Therapies Snippet / Teaser: The global Generalized Myasthenia Gravis (gMG) market is witnessing accelerated growth as awareness improves, advanced biologic therapies gain adoption, and rare-disease healthcare infrastructure expands worldwide. With rising diagnosis rates and strong therapy pipelines, gMG is emerging as a high-value segment in autoimmune and neuromuscular disorder treatment. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72089 1. Keyword Definition
Generalized Myasthenia Gravis (gMG) Market is expected to reach $9.8 billion by …
Generalized myasthenia gravis (gMG) is a rare, chronic autoimmune neuromuscular disorder characterized by muscle weakness, fatigue, and impaired communication between nerves and muscles. It is caused by autoantibodies-primarily against acetylcholine receptors (AChR) or muscle-specific kinase (MuSK)-that disrupt neuromuscular transmission. gMG significantly impacts patients' quality of life, often leading to difficulties in mobility, vision, swallowing, and breathing. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72089 Historically, treatment revolved around acetylcholinesterase inhibitors
Generalized Myasthenia Gravis (gMG) market dynamics are anticipated to change by …
The generalized myasthenia gravis (gMG) market dynamics are anticipated to change in the coming years owing to the expected approval of emerging therapies focused on treating gMG during the forecast period of 2021‒2034. There are presently a few key players in the gMG market, including Alexion/Astrazeneca, argenx, UCB, Horizon, Roche, and others. view detailed report here: https://olympusresearchglobal.com/report-detail/generalized-myasthenia-gravis-gmg-market-insights-epidemiology-market-forecast-2034/ Source: https://olympusresearchglobal.com/ View all Reports: https://olympusresearchglobal.com/report/ The landscape of the generalized myasthenia gravis (gMG) market is poised